Patents
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
09/2014
09/03/2014EP2771011A1 Chemical compounds
09/02/2014US8822683 CDK inhibitors
09/02/2014US8822464 N-aryl-piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
08/2014
08/28/2014WO2014130693A1 Inhibitors of bruton's tyrosine kinase
08/28/2014WO2014128612A1 Quinazolin-4-one derivatives
08/28/2014WO2013134288A9 Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
08/28/2014US20140243359 Adenine derivatives having immunomodulating anti-inflammatory and analgesic activity
08/28/2014US20140243358 Method of preventing and treating hepatic disease using a2b adenosine receptor antagonists
08/27/2014EP2768822A2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
08/26/2014US8816074 2′-fluoro-6′-methylene carbocyclic nucleosides and methods of treating viral infections
08/26/2014US8815829 3′-azido purine nucleotide prodrugs for treatment of viral infections
08/21/2014WO2014125410A1 N-substituted heterocyclic derivatives as kinase inhibitors
08/21/2014US20140235643 Novel quinoxaline inhibitors of pi3k
08/19/2014US8809402 Oxazolone and pyrrolidinone-substituted biphenyls as P2X3 and P2X2/3 antagonists
08/19/2014US8809351 Antiviral compound and cox-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib
08/19/2014US8809349 Processes for preparing isoquinolinones and solid forms of isoquinolinones
08/14/2014WO2014124458A1 Compositions and methods for treating neurodegenerative diseases
08/14/2014US20140228378 N-(Benzimimdazol-2-yl)-Cyclopropane Carboxamides as Lysophosphatidic Acid Antagonists
08/14/2014US20140228283 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
08/14/2014US20140227183 Small-molecule hsp90 inhibitors
08/13/2014CN103987712A 2',3'-二脱氧-2'-α-氟-2'-β-C-甲基核苷和其前药 2 ', 3'-dideoxy -2'-α- fluoro -2'-β-C- methyl-nucleosides and their prodrugs
08/13/2014CN103980276A 槲皮素咖啡因共晶 Quercetin caffeine eutectic
08/13/2014CN101304977B 具有全氟烷基的核酸碱类和其制备方法 Nucleic bases having a perfluoroalkyl group and a method for its preparation
08/12/2014US8802684 Adenine derivatives
08/12/2014US8802674 Aminopyrimidine derivatives as LRRK2 modulators
08/12/2014US8802657 Compounds useful as Raf kinase inhibitors
08/07/2014WO2014120748A1 2,6,7,8 substituted purines as hdm2 inhibitors
08/07/2014WO2011123751A3 Heterocyclic compounds and their use as pi3k inhibitors
08/07/2014US20140221407 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
08/07/2014US20140221401 Methods and compositions for treating pain
08/07/2014US20140221366 Substituted Azaheterocycles for the Treatment of Cancer
08/07/2014US20140220109 Novel cochleate formulations
08/06/2014CN103974954A 调节激酶的化合物、含有它们的组合物及其用途 Compounds that modulate kinases, compositions containing them and their use
08/06/2014CN103965276A 从野马追中快速分离纯化单体化合物的方法 The method is rapid separation and purification of the monomer compounds from the Mustang chase
08/06/2014CN103524503B 多索茶碱半水化合物 Doxofylline hemihydrate
08/06/2014CN102260260B 8-苯基黄嘌呤类化合物、其制备方法、包含该化合物的药物组合物及其用途 8-phenyl-xanthine compounds, methods for their preparation, pharmaceutical compositions comprising the compounds and their use
08/06/2014CN102159576B 肝适能制备的改良方法 Liver fitness improved method for preparing the
08/05/2014US8796293 Purine and deazapurine derivatives as pharmaceutical compounds
08/05/2014US8796292 Selective antibacterials for clostridium difficile infections
08/05/2014US8796291 A3 adenosine receptor antagonists and partial agonists
08/05/2014US8796290 Substituted fused pyrimidine compounds, its preparation and uses thereof
07/2014
07/31/2014WO2014115077A1 Substituted purinone compounds
07/31/2014US20140213737 Antibacterial antisense oligonucleotide and method
07/30/2014CN103958513A 6-羟基嘌呤衍生物盐酸盐 6-hydroxy purine derivative hydrochloride
07/30/2014CN103951667A 多晶型 Polymorph
07/29/2014US8791259 Process for the preparation of Tenofovir
07/29/2014US8791126 2-alkynyl-N9-propargyladenine and medicinal use thereof
07/29/2014US8790655 Conjugates of synthetic TLR agonists and uses therefor
07/24/2014WO2014113671A1 Inhibiting the transient receptor potential a1 ion channel
07/24/2014US20140206697 Haloaryl substituted aminopurines, compositions thereof,and methods of treatment therewith
07/24/2014US20140206685 Heterocyclic kinase inhibitors
07/24/2014US20140206684 Certain chemical entities, compositions and methods
07/24/2014US20140206650 Inhibiting the transient receptor potential a1 ion channel
07/23/2014EP2755977A1 6, 8- disubstituted purine compositions and their pharmaceutical and cosmetic use
07/23/2014CN103936742A 含嘌呤基的新型pi3k抑制剂及其制备方法和应用 The new pi3k inhibitors and their preparation and application of purine base
07/23/2014CN103936741A 无定形利拉利汀及其制备方法 Amorphous Linagliptin its preparation method
07/23/2014CN103936740A 黄嘌呤衍生物 Xanthine derivatives
07/23/2014CN103936739A 黄嘌呤衍生物 Xanthine derivatives
07/23/2014CN103936738A 黄嘌呤衍生物 Xanthine derivatives
07/23/2014CN103936737A 黄嘌呤衍生物 Xanthine derivatives
07/23/2014CN102850354B 高纯度cbz-万乃洛韦的制备方法 High purity cbz- square is prepared Lowe's
07/23/2014CN102177159B 用于治疗变应性、炎性和感染性疾病的嘌呤衍生物 For the treatment of allergic, inflammatory and infectious diseases, purine derivatives
07/22/2014US8785456 Substituted isoquinolin-1(2H)-ones, and methods of use thereof
07/22/2014US8785455 Polymorph of linagliptin benzoate
07/22/2014US8785454 Heterocyclic compounds and uses thereof
07/22/2014US8785453 Arylpiperazine-containing purine derivatives and uses thereof
07/17/2014US20140200229 Carbocyclic nucleosides and their pharmaceutical use and compositions
07/16/2014CN103923083A 一种腺嘌呤合成工艺 One kind of adenine synthesis process
07/16/2014CN103923049A 黄芩素咖啡因共无定型物 Scutellarein caffeine altogether amorphous substance
07/16/2014CN103923021A 适用作e1活化酶抑制剂的杂芳基化合物 Activating enzyme inhibitors suitable for e1 heteroaryl compound
07/16/2014CN102643277B 更昔洛韦的精制方法 Purification method ganciclovir
07/15/2014US8779131 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
07/10/2014US20140194447 Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies
07/03/2014US20140187772 Pyrazole compounds useful as protein kinase inhibitors
07/02/2014CN103896944A 别嘌醇的提纯方法 Purification methods allopurinol
07/02/2014CN102245607B 吗啉代嘌呤衍生物 Morpholino purine derivative
07/01/2014US8765940 Heterocyclic compounds and their uses
07/01/2014US8765775 Anti-angiogenic compounds
07/01/2014US8765772 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
06/2014
06/26/2014WO2014097314A1 An improved process for the preparation of linagliptin
06/26/2014WO2014094312A1 Method for synthesizing nucleoside amino acid derivatives through enzyme catalysis
06/26/2014US20140179718 Phosphatidylinositol 3-kinase inhibitors
06/26/2014US20140179689 Novel rho kinase inhibitors and methods of use
06/25/2014EP2744810A1 Tenofovir alafenamide hemifumarate
06/25/2014CN1646141B 用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物 For the treatment of viral infections and abnormal cell proliferation modified nucleoside compounds
06/25/2014CN103889972A 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烷基醇的衍生物 A phosphodiesterase inhibitor 1-phenyl-2-pyridinyl alkyl alcohols derivatives
06/24/2014US8759515 Process for the preparation of tenofovir disoproxil fumarate
06/24/2014US8759361 2-phenoxy pyrimidinone analogues
06/24/2014US8759360 Purine compounds
06/24/2014US8759359 Substituted heteroaryl fused derivatives as PI3K inhibitors
06/19/2014US20140170110 Pyridin-2(1h)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
06/18/2014EP2742048A1 Inhibiting transient receptor potential ion channel trpa1
06/18/2014CN103864797A Compounds with nerve protection function and application thereof
06/18/2014CN103864793A Substituted purin-9-acetamino isohydroxamic acid histone deacetylase inhibitor and preparation method and application thereof
06/18/2014CN103864792A Heterocyclic nitrogen compound acting as tyrosine kinase inhibitor
06/18/2014CN103864791A Entecavir derivative and preparation method thereof
06/18/2014CN103864653A Compounds for reducing intraocular pressure and use thereof
06/18/2014CN101987851B Crystal forms of Acyclovir sodium dihydrate and preparation method thereof
06/17/2014US8754065 Tenofovir alafenamide hemifumarate
06/12/2014US20140163051 Use and Application of a Pharmaceutical Composition Containing a Mixture of Natural-Origin Heterocyclical Guanidine, For Cosmetology, Wound Healing, Focal Dystonia and Muscular Spasm- Related Clinical Pathologies
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 120